We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Blasts FDA Over Pravachol Generic Launch

Law360 (October 24, 2005, 12:00 AM EDT) -- The FDA abused its discretion by triggering too early Teva Pharmaceutical Inc.’s 180-day market exclusivity for a generic cholesterol drug, according to a federal court’s order granting injunctive relief to the...
To view the full article, register now.